BIVI - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On BioVie Inc. - BIVI | Benzinga
NEW YORK, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of BioVie Inc. ("BioVie" or the "Company") (NASDAQ:BIVI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
The investigation concerns whether BioVie and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here for information about joining the class action]
On September 26, 2023, BioVie announced completion of the last treatment visit in its Phase 3 clinical trial of NE3107. On November 8, 2023, BioVie revealed that "during routine monitoring of blinded data from our Phase ...